Puri Ophthalmology announced that the company held the 5th meeting of the 4th board of directors on July 10, 2026 to review and pass the bill to appoint Gao Wen as the company's general manager, and the term of office will expire until the end of the term of the fourth board of directors. Gao Wen has held positions such as the compliance risk control director of Shanghai Hengchuan Investment Management Co., Ltd., and has served as the director of the company's audit and risk control center. After becoming general manager, he is no longer also the deputy general manager. As of the date of disclosure of the announcement, Gao Wen did not hold shares, had no relationships, and his qualifications met the requirements.

Puri Ophthalmology announced that the company held the 5th meeting of the 4th board of directors on July 10, 2026 to review and pass the bill to appoint Gao Wen as the company's general manager, and the term of office will expire until the end of the term of the fourth board of directors. Gao Wen has held positions such as the compliance risk control director of Shanghai Hengchuan Investment Management Co., Ltd., and has served as the director of the company's audit and risk control center. After becoming general manager, he is no longer also the deputy general manager. As of the date of disclosure of the announcement, Gao Wen did not hold shares, had no relationships, and his qualifications met the requirements.